Pengcheng Yu

440 total citations
17 papers, 211 citations indexed

About

Pengcheng Yu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Pengcheng Yu has authored 17 papers receiving a total of 211 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Immunology. Recurrent topics in Pengcheng Yu's work include Cancer Immunotherapy and Biomarkers (4 papers), Gastric Cancer Management and Outcomes (4 papers) and Hippo pathway signaling and YAP/TAZ (3 papers). Pengcheng Yu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Gastric Cancer Management and Outcomes (4 papers) and Hippo pathway signaling and YAP/TAZ (3 papers). Pengcheng Yu collaborates with scholars based in China, Singapore and Saint Kitts and Nevis. Pengcheng Yu's co-authors include Di Long, Sen Zhang, Chengcheng Liao, Xue‐Mei You, Jian‐Hong Zhong, Lequn Li, Xiaoli Liao, Yu Wang, Fa‐Xing Yu and Minyi Jia and has published in prestigious journals such as The EMBO Journal, Developmental Cell and Annals of Oncology.

In The Last Decade

Pengcheng Yu

16 papers receiving 204 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pengcheng Yu China 8 94 62 47 44 26 17 211
Steven E. Pilley United Kingdom 6 118 1.3× 115 1.9× 84 1.8× 19 0.4× 17 0.7× 7 291
Lola Martínez Spain 8 38 0.4× 125 2.0× 39 0.8× 28 0.6× 19 0.7× 15 245
McKay Mullen United States 8 58 0.6× 98 1.6× 32 0.7× 20 0.5× 32 1.2× 15 228
Yukun Kuang China 8 102 1.1× 59 1.0× 75 1.6× 68 1.5× 5 0.2× 25 250
Ren Yamada Japan 9 75 0.8× 94 1.5× 35 0.7× 15 0.3× 19 0.7× 22 270
Elisa M. Noll Germany 4 100 1.1× 171 2.8× 19 0.4× 26 0.6× 23 0.9× 5 249
Fang Zheng China 10 137 1.5× 73 1.2× 129 2.7× 24 0.5× 7 0.3× 22 287
Julia Bolik Germany 5 69 0.7× 63 1.0× 43 0.9× 10 0.2× 14 0.5× 6 184
Bingbing Lu China 8 62 0.7× 181 2.9× 21 0.4× 36 0.8× 18 0.7× 10 242
Ulrike Heinicke Germany 12 79 0.8× 297 4.8× 49 1.0× 48 1.1× 19 0.7× 20 405

Countries citing papers authored by Pengcheng Yu

Since Specialization
Citations

This map shows the geographic impact of Pengcheng Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengcheng Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengcheng Yu more than expected).

Fields of papers citing papers by Pengcheng Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pengcheng Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengcheng Yu. The network helps show where Pengcheng Yu may publish in the future.

Co-authorship network of co-authors of Pengcheng Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Pengcheng Yu. A scholar is included among the top collaborators of Pengcheng Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pengcheng Yu. Pengcheng Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ren, Yiping, Yu‐San Han, Pengcheng Yu, et al.. (2025). Chloroplast-targeting gold nanoclusters promoting leafy and fruit vegetables yields through improving photosynthesis. Plant Physiology and Biochemistry. 223. 109852–109852.
2.
3.
Wang, Yu, Yuwen Zhu, Pengcheng Yu, et al.. (2024). Angiomotin cleavage promotes leader formation and collective cell migration. Developmental Cell. 60(1). 101–118.e7. 3 indexed citations
4.
Wang, Yu, Yu Wang, Yuwen Zhu, et al.. (2023). Proteolytic activation of angiomotin by DDI2 promotes angiogenesis. The EMBO Journal. 42(15). e112900–e112900. 8 indexed citations
5.
6.
Yu, Pengcheng, Weiyang He, Yanqiang Zhang, et al.. (2022). SFRP4 Is a Potential Biomarker for the Prognosis and Immunotherapy for Gastric Cancer. Journal of Oncology. 2022. 1–15. 6 indexed citations
7.
Hu, Can, et al.. (2022). High HDAC5 expression correlates with a poor prognosis and the tumor immune microenvironment in gastric cancer. Annals of Translational Medicine. 10(18). 990–990. 4 indexed citations
8.
9.
Li, Yuan, Jingli Xu, Pengcheng Yu, et al.. (2022). CD3D Is an Independent Prognostic Factor and Correlates With Immune Infiltration in Gastric Cancer. Frontiers in Oncology. 12. 913670–913670. 9 indexed citations
10.
Han, Yang, Peipei Liu, Yang Qiu, et al.. (2021). Effective virus-neutralizing activities in antisera from the first wave of severe COVID-19 survivors. JCI Insight. 6(4). 9 indexed citations
11.
Wang, Yu, Yuwen Zhu, Yuan Gu, et al.. (2021). Stabilization of Motin family proteins in NF2-deficient cells prevents full activation of YAP/TAZ and rapid tumorigenesis. Cell Reports. 36(8). 109596–109596. 23 indexed citations
12.
Liang, Chengyuan, Yuzhi Liu, Juan Li, et al.. (2021). Insights into forsythia honeysuckle (Lianhuaqingwen) capsules: A Chinese herbal medicine repurposed for COVID-19 pandemic. Phytomedicine Plus. 1(2). 100027–100027. 27 indexed citations
13.
14.
15.
Yu, Pengcheng, Di Long, Chengcheng Liao, & Sen Zhang. (2018). Association between density of tumor-infiltrating lymphocytes and prognoses of patients with gastric cancer. Medicine. 97(27). e11387–e11387. 43 indexed citations
16.
Yu, Pengcheng, Di Long, Xiaoli Liao, et al.. (2017). Prognostic value of PD -L1 expression in patients with primary solid tumors. Oncotarget. 9(4). 5058–5072. 50 indexed citations
17.
Qu, Xiaoyan, Jinping Zhao, Minghui Zhao, et al.. (2012). Tumor Response and Survival in Patients with Advanced Non-Small-Cell Lung Cancer: The Predictive Value of Chemotherapy-Induced Changes in Fibrinogen. Annals of Oncology. 23. xi48–xi48. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven E. Pilley Breakdown of academic impact, for papers by Lola Martínez Breakdown of academic impact, for papers by McKay Mullen Breakdown of academic impact, for papers by Yukun Kuang Breakdown of academic impact, for papers by Ren Yamada Breakdown of academic impact, for papers by Elisa M. Noll Breakdown of academic impact, for papers by Fang Zheng Breakdown of academic impact, for papers by Julia Bolik Breakdown of academic impact, for papers by Bingbing Lu Breakdown of academic impact, for papers by Ulrike Heinicke
Rankless by CCL
2026